Patent details

Basic Information

Publication number:

EP2376075

PCT Application Number:

PCT/US/2009/069298

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP098357965

PCT Publication Number:

WO/2010/075444

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NASAL FORMULATIONS OF METOCLOPRAMIDE

French Title of Invention:

FORMULATIONS NASALES DE MÉTOCLOPRAMIDE

German Title of Invention:

NASALE METOCLOPRAMID-FORMULIERUNGEN

SPC Number:

Dates

Filing date:

22/12/2009

Grant date:

08/04/2015

EP Publication Date:

08/04/2015

PCT Publication Date:

01/07/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/10/2011

EP B1 Publication Date:

08/04/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

22/12/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/12/2009

 

 

Name:

Evoke Pharma Inc.

Address:

505 Lomas Santa Fe Drive, Suite 270, Solana Beach, CA 92075, United States (US)

Inventor

1

Name:

D'ONOFRIO Matthew, J.

Address:

United States (US)

2

Name:

GONYER David, A.

Address:

United States (US)

3

Name:

SHAH Shirish, A.

Address:

United States (US)

4

Name:

MADDEN Stuart, J.

Address:

United States (US)

Priority

Priority Number:

140034 P

Priority Date:

22/12/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/166;

Annual Fees

Annual Fee Due Date:

31/12/2025

Annual Fee Number:

17

Annual Fee Amount:

246 Euro

Expected Payer:

Last Annual Fee Payment Date:

13/12/2024

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages